Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió acceptadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/176209
Is availability of artesunate associated with the prognosis of imported malaria in Spain?
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Although there is a lot of aspects we stil need to understand about treatment with artemisinins[1], there is no doubt about their efficacy in treating malaria. Artesunate (AS) has demonstrated its superiority against quinine for treatment of severe malaria in terms of reduction of mortality in different randomized clinical trials performed in endemic countries and subsequent meta-analysis[2-4]. Despite having been established as the first line treatment by WHO and several national guidelines[5,6], its full implementation in non-endemic countries has not been completed.
Matèries
Citació
Citació
CAMPRUBÍ, Daniel, MARTÍ SOLER, Helena, SUBIRÀ, Carme, FERRER, Elisabet, MUÑOZ, José. Is availability of artesunate associated with the prognosis of imported malaria in Spain?. _Travel Medicine and Infectious Disease_. 2020. Vol. 37, núm. 101695. [consulta: 20 de gener de 2026]. ISSN: 1477-8939. [Disponible a: https://hdl.handle.net/2445/176209]